These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 28598322)
41. Comparative study of elderly-onset rheumatoid arthritis and young-onset rheumatoid arthritis in a Colombian population: clinical, laboratory and HLA-DRB1 findings. Spinel-Bejarano N; Quintana G; Heredia R; Yunis JJ; Caminos JE; Garcés MF; Rondon F; Iglesias-Gamarra A Clin Exp Rheumatol; 2013; 31(1):40-6. PubMed ID: 22935200 [TBL] [Abstract][Full Text] [Related]
42. An evidence-based approach to laboratory tests in usual care of patients with rheumatoid arthritis. Pincus T; Gibson KA; Shmerling RH Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-23-8. PubMed ID: 25365085 [TBL] [Abstract][Full Text] [Related]
43. Efficacy of serum angiopoietin-1 measurement in the diagnosis of early rheumatoid arthritis. Ishikawa A; Okada J; Nishi K; Hirohata S Clin Exp Rheumatol; 2011; 29(4):604-8. PubMed ID: 21906428 [TBL] [Abstract][Full Text] [Related]
44. The role of anti-cyclic citrullinated peptide antibodies in predicting rheumatoid arthritis. Rexhepi S; Rexhepi M; Sahatçiu-Meka V; Tafaj A; Izairi R; Rexhepi B Reumatizam; 2011; 58(1):12-4. PubMed ID: 21751570 [TBL] [Abstract][Full Text] [Related]
45. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis. Liu X; Jia R; Zhao J; Li Z J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936 [TBL] [Abstract][Full Text] [Related]
46. Contribution of anti-cyclic citrullinated peptide antibody and rheumatoid factor to the diagnosis of arthropathy in haemochromatosis. Aigner E; Schmid I; Osterreicher CH; Zwerina J; Schett G; Strasser M; Niksic F; Hohla F; Ramsauer T; Dorn U; Patsch W; Datz C Ann Rheum Dis; 2007 Sep; 66(9):1249-51. PubMed ID: 17456529 [TBL] [Abstract][Full Text] [Related]
47. Rheumatoid Factor, Anti-Cyclic Citrullinated Peptide Antibody, C-Reactive Protein, and Erythrocyte Sedimentation Rate for the Clinical Diagnosis of Rheumatoid Arthritis. Shen R; Ren X; Jing R; Shen X; Chen J; Ju S; Yang C Lab Med; 2015; 46(3):226-9. PubMed ID: 26199263 [TBL] [Abstract][Full Text] [Related]
48. The value of HLA-DRB1 shared epitope, -308 tumor necrosis factor-alpha gene promoter polymorphism, rheumatoid factor, anti-citrullinated peptide antibodies, and early erosions for predicting radiological outcome in recent-onset rheumatoid arthritis. Reneses S; González-Escribano MF; Fernández-Suárez A; Pestana L; Davila B; Wichmann I; García A J Rheumatol; 2009 Jun; 36(6):1143-9. PubMed ID: 19411391 [TBL] [Abstract][Full Text] [Related]
49. A multicenter study of clinical and laboratory findings of palindromic rheumatism in Iran. Khabbazi A; Hajialiloo M; Kolahi S; Soroosh M; Esalatmanesh K; Sharif S Int J Rheum Dis; 2012 Aug; 15(4):427-30. PubMed ID: 22898224 [TBL] [Abstract][Full Text] [Related]
50. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712 [TBL] [Abstract][Full Text] [Related]
51. [Diagnostic value of serum anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis]. Yang CL; Zhou YR; Zhou F; Li J Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1277-9. PubMed ID: 17715048 [TBL] [Abstract][Full Text] [Related]
52. Autoantibody profiling in patients with very early rheumatoid arthritis: a follow-up study. Nell-Duxneuner V; Machold K; Stamm T; Eberl G; Heinzl H; Hoefler E; Smolen JS; Steiner G Ann Rheum Dis; 2010 Jan; 69(1):169-74. PubMed ID: 19153104 [TBL] [Abstract][Full Text] [Related]
53. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity. Shakiba Y; Koopah S; Jamshidi AR; Amirzargar AA; Massoud A; Kiani A; Nicknam MH; Nazari B; Nikbin B Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):147-56. PubMed ID: 24659118 [TBL] [Abstract][Full Text] [Related]
54. Comparison of anti-mutated citrullinated vimentin, anti-cyclic citrullinated peptides, anti-glucose-6-phosphate isomerase and anti-keratin antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients. Zhu T; Feng L Int J Rheum Dis; 2013 Apr; 16(2):157-61. PubMed ID: 23773638 [TBL] [Abstract][Full Text] [Related]
55. Anti-cyclic citrullinated peptide antibodies in patients with sarcoidosis. Kobak S; Ylmaz H; Sever F; Duran A; Sen N Sarcoidosis Vasc Diffuse Lung Dis; 2014 Oct; 31(3):206-10. PubMed ID: 25363220 [TBL] [Abstract][Full Text] [Related]
56. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis. Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694 [TBL] [Abstract][Full Text] [Related]
57. Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor. Bossuyt X; Coenen D; Fieuws S; Verschueren P; Westhovens R; Blanckaert N Ann Rheum Dis; 2009 Feb; 68(2):287-9. PubMed ID: 19139208 [No Abstract] [Full Text] [Related]
58. Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis? Girelli F; Foschi FG; Bedeschi E; Calderoni V; Stefanini GF; Martinelli MG Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):127-30. PubMed ID: 15180353 [TBL] [Abstract][Full Text] [Related]
59. [Rheumatoid arthritis]. Strunk J; Lange U; Müller-Ladner U Dtsch Med Wochenschr; 2005 Jul; 130(30):1761-8; quiz 1769-72. PubMed ID: 16049881 [TBL] [Abstract][Full Text] [Related]